课题基金 / 基金详情

D4T & DDI IN CHILDREN ON LT D4T MONO TX & D4T VS D4T/DDI IN CHILDREN ON LT AZT TX

D4T & DDI IN CHILDREN ON LT D4T MONO TX & D4T VS D4T/DDI IN CHILDREN ON LT AZT TX
D4T
批准号:
6276210
负责人:
MYRON J LEVIN
金额:
$1.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

MYRON J LEVIN的其他基金

相似基金

相关文献

中文摘要
翻译
司他夫定(D4T)和二磷酸核苷(Ddi)是核苷类似物 对成人有效;ddi对儿童也有效;d4T是安全的 对儿童有抗病毒活性。随着证据的积累 这表明联合治疗可能比单一治疗更有希望- 药物治疗在HIV感染长期管理中的应用研究 将评估d4T+ddi对血浆HIV RNA浓度的影响 口服给药48周。安全性与药代动力学 还将评估联合疗法的特性。
英文摘要
Stavudine (d4T) & didanosine (ddI) are nucleoside analogues with efficacy in adults; ddI is also efficacious in children; d4T is safe & has antiviral activity in children. With accumulating evidence suggesting that combination therapy may hold more promise than single- agent therapy in the long-term management of HIV infection, this study will evaluate the effect on plasma HIV RNA concentrations of d4T+ddI administered orally for 48 weeks. The safety & pharmacokinetic properties of the combination therapy also will be assessed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10112818
  • 项目类别:
  • 资助金额:
    $70.5万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    9886187
  • 项目类别:
  • 资助金额:
    $71.55万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10580099
  • 项目类别:
  • 资助金额:
    $68.53万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10363620
  • 项目类别:
  • 资助金额:
    $69.98万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
海外基金